A study published in the Annals of Internal Medicine showed that, while intensive systolic blood pressure control increased the risk for chronic kidney disease events, it was outweighed by the potential cardiovascular benefits. The study is a subgroup analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).